✦ LIBER ✦

Cancer drugs: time to rethink clinical endpoints?

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A retrospective study of the time to cli

✍ Nima Sharifi; William L. Dahut; Seth M. Steinberg; William D. Figg; Christopher 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

Gender Differences in Drug Bioequivalenc

✍ Koren, G; Nordeng, H; MacLeod, S 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 415 KB

Dietary HDAC inhibitors: time to rethink

✍ Dashwood, R. H. 📂 Article 📅 2005 🏛 Oxford University Press 🌐 English ⚖ 462 KB

Time to rethink clinically important out

✍ Nancy M. Heddle; Donald M. Arnold; Kathryn E. Webert 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 155 KB

The assessment of drug calculation skill

✍ Kerri Wright 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Protocol of the Definition for the Asses

✍ Bellera, Carine A.; Pulido, Marina; Gourgou, Sophie; Collette, Laurence; Doussau 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 918 KB